Answers are grounded in this paper and cite their sources.
Objective. To assess the prevalence, clinical-psychopathological characteristics, and need for treatment of depressive disorders in patients with psoriasis (Ps) and psoriatic arthritis (PsA) in a primary care setting. Materials and methods. A cross-sectional screening study was conducted, followed by an in-depth clinical-psychopathological analysis. Screening for the risk of affective disorders was performed on 6,113 patients attending general practice appointments using the V. N. Krasnov questionnaire. Of the 3,074 patients with a positive screening result, 2,516 (81.9 %) underwent a psychiatric consultation to verify the diagnosis. An in-depth assessment was performed on 101 patients with Ps and/or PsA. Results. Depressive disorders were confirmed in 53.2 % of patients in the at-risk group. Among patients with Ps and PsA, depressive disorders were identified in 53.4 % and 61.1 % of cases, respectively, predominantly in chronic forms. Mixed anxiety-depressive disorders were observed significantly more frequently in patients with PsA. The need for antidepressant prescription was 22.2 % for psoriasis (Ps) and 25.6 % for psoriatic arthritis (PsA). Conclusion. A high prevalence and specific nature of comorbid depressive disorders were established in patients with Ps and PsA. The results justify the need to implement routine screening and develop collaboration algorithms among general practitioners, dermatologists, rheumatologists, and psychiatrists.
No takes yet. Share an insight, caveat, or question.
Политова et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: